Potentiation of the antibody response to inactivated A2-Hong Kong vaccines by previous heterotypic influenza virus infection.
D000818:Animals; D000910:Antibodies, Heterophile; D000917:Antibody Formation; D002501:Centrifugation, Zonal; D006224:Cricetinae / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D004372:Ducks; D004739:England; D006385:Hemagglutination Inhibition Tests; D006723:Hong Kong; D006736:Horses; D006801:Humans; D007114:Immunization; D007252:Influenza Vaccines; D009975:Orthomyxoviridae / Q000276:immunology*; D011995:Recombination, Genetic; D012846:Singapore; D013045:Species Specificity; D013552:Swine; D013997:Time Factors
D000910:Antibodies, Heterophile; D007252:Influenza Vaccines